Genous, the antibody-coated stent developed by Hong Kong company OrbusNeich, is safe and effective in the treatment of ST-elevation myocardial infarction (STEMI). Taking its name from the distinctive pattern it produces on an electrocardiogram, STEMI is generally taken to be the ...
Clinica
Genous stent promising in challenging patient groups, trials suggest
03 February 2010
Elizabeth Cairns
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- TCT 2011: Boston's next-gen Promus Element succeeds in long lesions; Ion beats older-gen stents
- EuroPCR 2011: DESs with absorbable polymers shown to beat those with durable polymers for the first time
- EuroPCR 2011: Biotronik's dissolving metal DES shows promise at six months
- St Jude halts FFR study earlier than expected on positive results
Other Informa News
EVENTS
19 March 2012
Montreux Convention and Music Centre, Switzerland
